Related references
Note: Only part of the references are listed.Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial
Marwan G. Fakih et al.
LANCET ONCOLOGY (2022)
Dietary Risk Factors and Odds of Colorectal Adenoma in Malaysia: A Case Control Study
Razinah Sharif et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2022)
KRAS-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer
Emerik Osterlund et al.
FRONTIERS IN ONCOLOGY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The current understanding on the impact of KRAS on colorectal cancer
Mingjing Meng et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Serum Tumor Markers Combined With Clinicopathological Characteristics for Predicting MMR and KRAS Status in 2279 Chinese Colorectal Cancer Patients: A Retrospective Analysis
Ning Zhao et al.
FRONTIERS IN ONCOLOGY (2021)
Metastatic Profile of Colorectal Cancer: Interplay Between Primary Tumor Location and KRAS Status
Zachary Zihui Yong et al.
JOURNAL OF SURGICAL RESEARCH (2020)
The Impact of KRAS Mutation on the Presentation and Prognosis of Non-Metastatic Colon Cancer: an Analysis from the National Cancer Database
Aaron Scott et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2020)
Right and left-sided colon cancers - specificity of molecular mechanisms in tumorigenesis and progression
Kavitha Mukund et al.
BMC CANCER (2020)
Targeting the MAPK Pathway in KRAS-Driven Tumors
Matthias Drosten et al.
CANCER CELL (2020)
Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis
Lauren C. Bylsma et al.
CANCER MEDICINE (2020)
KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study
Hector Eduardo Sanchez-Ibarra et al.
PLOS ONE (2020)
Impact of primary colorectal Cancer location on the KRAS status and its prognostic value
Ming-zhi Xie et al.
BMC GASTROENTEROLOGY (2019)
G12V and G12C mutations in the gene KRAS are associated with a poorer prognosis in primary colorectal cancer
Tamuro Hayama et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2019)
Knowledge and practice of colorectal cancer screening in an urban setting: cross-sectional survey of primary care physicians in government clinics in Malaysia
Chor Yau Ooi et al.
SINGAPORE MEDICAL JOURNAL (2019)
Update on Sporadic Colorectal Cancer Genetics
Karin M. Hardiman
CLINICS IN COLON AND RECTAL SURGERY (2018)
Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer
Stephan Paschke et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature
Burcin Baran et al.
GASTROENTEROLOGY RESEARCH (2018)
Global patterns and trends in colorectal cancer incidence and mortality
Melina Arnold et al.
GUT (2017)
Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia
Wai Kien Yip et al.
APMIS (2013)
Are high initial CEA and CA 19-9 levels associated with the presence of K-ras mutation in patients with metastatic colorectal cancer?
Fatih Selcukbiricik et al.
TUMOR BIOLOGY (2013)
Missense Mutations in MLH1, MSH2, KRAS, and APC Genes in Colorectal Cancer Patients in Malaysia
Nor Azian Abdul Murad et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Sanger sequencing in routine KRAS testing: a review of 1720 cases from a pathologist's perspective
Umberto Malapelle et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
Diet, physical activity, and body size associations with rectal tumor mutations and epigenetic changes
Martha L. Slattery et al.
CANCER CAUSES & CONTROL (2010)
KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis
Paloma Cejas et al.
PLOS ONE (2009)
Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer
Jens Neumann et al.
PATHOLOGY RESEARCH AND PRACTICE (2009)
Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer
Salvatore Artale et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The MAPK signalling pathways and colorectal cancer
JY Fang et al.
LANCET ONCOLOGY (2005)
K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study
M Brink et al.
CARCINOGENESIS (2003)
Kirsten ras mutations in patients with colorectal cancer:: the 'RASCAL II' study
HJN Andreyev et al.
BRITISH JOURNAL OF CANCER (2001)
CEA is the major PHA-L-reactive glycoprotein in colon carcinoma cell lines and tumors:: Relationship between K-ras activation and β1-6 branching of N-linked carbohydrate on CEA
DC Wojciechowicz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
